Aspira Stock Today


USD 0.77  0.04  5.48%   

Market Performance
1 of 100
Odds Of Distress
Less than 3
Aspira Womans is trading at 0.77 as of the 5th of July 2022. This is a 5.48 percent increase since the beginning of the trading day. The stock's open price was 0.73. Aspira Womans has a very small chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Aspira Womans Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of June 2021 and ending today, the 5th of July 2022. Please note, there could be an existing legal relationship between Aspira Womans Health (AWH) and ASPIRA WOMENS HEALTH (VRML). Click here to learn more.
Fiscal Year End
Business Domain
Health Care Equipment & Services
IPO Date
27th of June 1996
Health Care
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. The company has 112.21 M outstanding shares of which 5.37 M shares are presently shorted by investors with about 4.23 days to cover. More on Aspira Womans Health

Moving together with Aspira Womans

0.67AAgilent Technologies Fiscal Year End 28th of November 2022 PairCorr
0.87BMRABiomerica Financial Report 26th of August 2022 PairCorr
0.79CNTGCentogene NV Earnings Call  TodayPairCorr
0.8COGlobal Cord Blood Earnings Call  TodayPairCorr

Moving against Aspira Womans

0.58CDKCdk Global Fiscal Year End 16th of August 2022 PairCorr
0.57RDBXRedbox Entertainment Normal TradingPairCorr

Aspira Womans Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Aspira Womans' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aspira Womans or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Aspira Womans Health has very high historical volatility over the last 90 days
Aspira Womans Health has some characteristics of a very speculative penny stock
The company reported the last year's revenue of 7.21 M. Reported Net Loss for the year was (35.01 M) with profit before taxes, overhead, and interest of 3.06 M.
Aspira Womans Health has about 26.86 M in cash with (32.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Aspira Womans Health has a frail financial position based on the latest SEC disclosures
Roughly 49.0% of the company shares are held by company insiders
Latest headline from Even after rising 18 percent this past week, Aspira Womens Health shareholders are still down 88 percent over the past year - Simply Wall St
New SymbolAWHHF
ChairmanBart Friedman
Fama & French Classification
Average Analyst Recommendation
Analysts covering Aspira Womans report their recommendations after researching Aspira Womans' financial statements, talking to executives and customers, or listening in on Aspira Womans' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Aspira Womans Health. The Aspira consensus assessment is calculated by taking the average forecast from all of the analysts covering Aspira Womans.
Strong Buy2 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Aspira Womans Health based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Aspira Womans Health financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares90.7 M111.2 M
Significantly Down
Slightly volatile
Weighted Average Shares Diluted90.7 M111.2 M
Significantly Down
Slightly volatile
Total Assets32.6 M41.1 M
Significantly Down
Total Liabilities9.3 M10.9 M
Fairly Down
Very volatile
Current Assets43.2 M40 M
Significantly Up
Current Liabilities8.5 M7.8 M
Significantly Up
Total Debt3.7 M4.1 M
Moderately Down
Gross Margin0.40.45
Fairly Down
Slightly volatile
Asset Turnover0.180.131
Significantly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Aspira Womans' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Aspira Womans' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aspira Womans' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aspira Womans' financial leverage. It provides some insight into what part of Aspira Womans' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Aspira Womans' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Aspira Womans deploys its capital and how much of that capital is borrowed.
Aspira Womans cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 3.78 M in debt with debt to equity (D/E) ratio of 0.17, which may show that the company is not taking advantage of profits from borrowing. Aspira Womans Health has a current ratio of 4.75, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Aspira Womans until it has trouble settling it off, either with new capital or with free cash flow. So, Aspira Womans' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aspira Womans Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aspira to invest in growth at high rates of return. When we think about Aspira Womans' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(28.12 Million)Share
Aspira Womans Health (AWH) is traded on NASDAQ Exchange in USA. It is located in 12117 Bee Caves Road, Building III, Suite 100, Austin, TX 78738, United States and employs 106 people. Aspira Womans is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with total capitalization of 82.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aspira Womans's market, we take the total number of its shares issued and multiply it by Aspira Womans's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Aspira Womans Health runs under null sector within null industry. The entity has 112.21 M outstanding shares of which 5.37 M shares are presently shorted by investors with about 4.23 days to cover. Aspira Womans Health has about 26.86 M in cash with (32.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Check Aspira Womans Probability Of Bankruptcy
Aspira Womans Health retains a total of 112.21 Million outstanding shares. Aspira Womans Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Aspira Ownership Details

Aspira Stock Price Odds Analysis

What are Aspira Womans' target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Aspira Womans jumping above the current price in 90 days from now is about 36.32%. The Aspira Womans Health probability density function shows the probability of Aspira Womans stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.6899. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aspira Womans will likely underperform. Additionally, the company has an alpha of 0.223, implying that it can generate a 0.22 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 0.77HorizonTargetOdds Above 0.77
63.60%90 days
Based on a normal probability distribution, the odds of Aspira Womans to move above the current price in 90 days from now is about 36.32 (This Aspira Womans Health probability density function shows the probability of Aspira Stock to fall within a particular range of prices over 90 days) .

Aspira Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Aspira Womans that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aspira Womans' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aspira Womans' value.
InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares4.7 M4.9 M
Vanguard Group IncCommon Shares3.1 M3.2 M
View Aspira Womans Diagnostics

Aspira Womans Historical Income Statement

Aspira Womans Health Income Statement is one of the three primary financial statements used for reporting Aspira's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Aspira Womans Health revenue and expense. Aspira Womans Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Aspira Womans Interest Expense is most likely to decrease significantly in the upcoming years. The last year's value of Interest Expense was reported at 48,000. The current Research and Development Expense is estimated to increase to about 5.7 M, while Consolidated Income is projected to decrease to (32.5 M). View More Fundamentals

Aspira Stock Against Markets

Picking the right benchmark for Aspira Womans stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aspira Womans stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aspira Womans is critical whether you are bullish or bearish towards Aspira Womans Health at a given time.

Similar Equity Warning - AWH

Aspira Womans Health was forked

The entity Aspira Womans Health with a symbol AWH was recently forked. You can potentially use ALLIED WORLD ASSURANCE with a symbol AWHHF from now on.

Aspira Womans Corporate Directors

Aspira Womans corporate directors refer to members of an Aspira Womans board of directors. The board of directors generally takes responsibility for the Aspira Womans' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Aspira Womans' board members must vote for the resolution. The Aspira Womans board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Eric Schwartz - Independent DirectorProfile
James Duffy - Independent DirectorProfile
Patrick SaintAignan - Independent DirectorProfile
Samuel Weinhoff - Independent DirectorProfile

Investing Aspira Womans Health

You need to understand the risk of investing before taking a position in Aspira Womans. The danger of trading Aspira Womans Health is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aspira Womans is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aspira Womans. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aspira Womans Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
82.2 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.